These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 4993941)

  • 1. [Passage of fetal cells into the maternal circulation in 461 women during pregnancy and in 1,000 women during labor].
    Restrepo A; Palacio S; Cano A; Campuzano G; López N
    Rev Colomb Obstet Ginecol; 1970; 21(4):405-15. PubMed ID: 4993941
    [No Abstract]   [Full Text] [Related]  

  • 2. [Practical problems of preventing Rh sensitization using immunological methods].
    Althoff W; Schellong G; Stahl M
    Rev Clin Esp; 1969 Sep; 114(6):515-24. PubMed ID: 4988856
    [No Abstract]   [Full Text] [Related]  

  • 3. [Massive feto-maternal and materno-fetal hemorrhage].
    Valbonesi M; Cinollo G; Rivabella L; Serra G
    Minerva Pediatr; 1978 Jul; 30(14):1149-52. PubMed ID: 97508
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention and treatment of Rh. isoimmunization. Results].
    Martínez M; Lozano G; Flores F; Fernández P; Garrido G
    Acta Obstet Ginecol Hisp Lusit; 1971 Mar; 19(2):149-57. PubMed ID: 4996734
    [No Abstract]   [Full Text] [Related]  

  • 5. [Selective Rh prevention in pregnancy].
    Helderweirt G
    Verh K Acad Geneeskd Belg; 1983; 45(3):261-74. PubMed ID: 6421025
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathogenesis of Rh immunization in primigravidas. Fetomaternal versus maternofetal bleeding.
    Scott JR; Beer AE; Guy LR; Liesch M; Elbert G
    Obstet Gynecol; 1977 Jan; 49(1):9-14. PubMed ID: 401536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Problem of the dose of immunoglobulins in the prevention of hemolytic disease of newborn due to materno-fetal incompatibility of antigen D, in case of massive feto-maternal hemorrhage].
    Mattone PG; Meriggi E; De Martin G
    Minerva Ginecol; 1972 May; 24(7):337-41. PubMed ID: 4211573
    [No Abstract]   [Full Text] [Related]  

  • 8. [Transplacental passage of fetal erythrocytes during pregnancy and the post-partum period].
    Palliez R; Delecour M; Monnier JC; Hutin A; Abdelatif M
    Rev Fr Gynecol Obstet; 1970 Oct; 65(10):579-84. PubMed ID: 4991521
    [No Abstract]   [Full Text] [Related]  

  • 9. Rho (D) immune prophylaxis. A double-blind cooperative study.
    White CA; Visscher RD; Visscher HC; Wade ME
    Obstet Gynecol; 1970 Sep; 36(3):341-6. PubMed ID: 4988961
    [No Abstract]   [Full Text] [Related]  

  • 10. [Course of pregnancy, labor and fetal development in Rh factor incompatibility].
    Rybalka AN; Tepper SN
    Pediatr Akus Ginekol; 1977; (4):35-7. PubMed ID: 412167
    [No Abstract]   [Full Text] [Related]  

  • 11. Fetomaternal blood group incompatibility studies in placental intervillous thrombosis.
    Batcup G; Tovey LA; Longster G
    Placenta; 1983; 4 Spec No():449-53. PubMed ID: 6672809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fetomaternal transfusion, rhesus immunization and prevention].
    Helderweirt G
    Verh K Acad Geneeskd Belg; 1974; 36(4):185-218. PubMed ID: 4216208
    [No Abstract]   [Full Text] [Related]  

  • 13. Foetal-maternal transfusion and rhesus sensitization.
    Pilkington R; Knox EG; Russell JK; Walker W
    J Obstet Gynaecol Br Commonw; 1966 Dec; 73(6):909-16. PubMed ID: 4959129
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of isoimmunization in the Rh factor in the obstetrical clinic of the Faculdade de Medicina da Universidade Federal de Goiáz].
    Brandão MB
    Matern Infanc (Sao Paulo); 1971; 30(3):291-6. PubMed ID: 4114902
    [No Abstract]   [Full Text] [Related]  

  • 15. [Alloimmunization. 1].
    Bowman J; Lorrain J
    Union Med Can; 1984 Mar; 113(3):154-5, 158-64. PubMed ID: 6428020
    [No Abstract]   [Full Text] [Related]  

  • 16. [Foetal-maternal alloimmunizations in the South-East area of the Venice province].
    Gessoni G; Valverde S; Giacomini A; Antico F; Salvadego M; Arreghini N; De Fusco G; Fezzi M; Marchiori G; Manoni F
    Minerva Ginecol; 2002 Aug; 54(4):333-8. PubMed ID: 12114866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current status of the use of immunosuppressive agents based on hyperimmune gamma globulins].
    Crespo Cortina M; Arroyo Bornstein A
    Ginecol Obstet Mex; 1972 Apr; 31(186):369-73. PubMed ID: 4112876
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immuno-hematology of obstetrical importance. (Technical notes)].
    Furfaro M
    Minerva Ginecol; 1970 Jan; 22(1):31-47. PubMed ID: 4987993
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on foetomaternal haemorrhage (FMH). Part I: Factors affecting foetomaternal haemorrhage.
    Cherian L; Bhargava M; Kumar S; Pinto de Rosario Y
    Indian J Med Res; 1974 Apr; 62(4):546-51. PubMed ID: 4215750
    [No Abstract]   [Full Text] [Related]  

  • 20. [Critical study of the results of an application of preventive treatment taking into account the systematic evaluation of feto-maternal hemorrhage].
    Huchet J; Crégut R; Briffoteaux P; Pinon F
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):203-5. PubMed ID: 4143442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.